Key facts
- It has raised $540K across 1 recorded rounds; the latest was Seed Round ($540K) in Jun 2025.
- Notable investors include gener8tor, VentureWell, University of Virginia, ACC InVenture Prize, INC. — 8 tracked in total.
- Phoenix-Aid has filed 1 Form D with the SEC, most recently Jul 2025 ($540K sold to 9 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for Phoenix-Aid
Funding rounds
1 roundsAbout Phoenix-Aid
Developer of a wound care dressing technology designed to accelerate healing and reduce infection-related complications. The company offers a nanocomposite carbon-polymer multilayer dressing that maintains a moist oxygenated environment, absorbs wound fluid without leakage, incorporates microporous barriers with germicidal properties, and supports extended wear with self-application design, enabling patients with chronic and acute wounds, including diabetic ulcers, to experience recovery, lower infection risk, and reduced frequency of dressing changes.
- Sector
- Healthcare
- HQ
- Madison, WI, United States
- Founded
- 2014
- Employees
- 4
- Website
- phoenixaid.bio/
- Ownership
- Privately Held (backing)
Phoenix-Aid doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Phoenix-Aid shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Phoenix-Aid in its N-PORT filings yet. We sweep new filings monthly.